Results 101 to 110 of about 2,648,667 (204)

Hadron therapy

, 2011
The hadrontherapy uses light charged particles beams (mainly proton and 12C ions)to irradiate tumors. These beams present a ballistic advantage with a maximum energydeposition at the end of the path (ie Bragg peak). A large dose can be delivered insidea deep tumor while the surrounding healthy tissues are preserved. Concerning the 12Cbeams, an enhanced
openaire   +1 more source

LITERATURE REVIEW ON LINACs AND FFAGs FOR HADRON THERAPY

, 2011
The document summarizes the recent papers, presentations and other public information on Radio-Frequency (RF) Linear Accelerators (linacs) and Fixed-Field Alternating-Gradient (FFAG) accelerators for hadron therapy.
ÁNGELES FAUS-GOLFE, UGO AMALDI, SILVIA VERDÚ-ANDRÉS   +2 more
core   +1 more source

Investigation of the Physical Properties of Different Ion Species at Hadron Therapy; A Comprehensive Study

Frontiers in Biomedical Technologies
Purpose: Recently, using hadrons as a therapeutic beam has been highly advised for radiation treatment of mainly deep-seated tumors due to the desired conforming of three-dimensional dose conformation onto tumor volume.
Ahmad Esmaili Torshabi
doaj   +1 more source

A high-resolution large-area detector for quality assurance in radiotherapy

Scientific Reports
Hadron therapy is an advanced radiation modality for treating cancer, which currently uses protons and carbon ions. Hadrons allow for a highly conformal dose distribution to the tumour, minimising the detrimental side-effects due to radiation received by
Andreia Maia Oliveira, Hylke B. Akkerman, Saverio Braccini, Albert J. J. M. van Breemen, Gerwin H. Gelinck, Natalie Heracleous, Johannes Leidner, Fabrizio Murtas, Bart Peeters, Marco Silari   +9 more
doaj   +1 more source

Hadron Radiotherapy Facilities in Japan

, 2003
Present status of proton and heavy-ion radiotherapy facilities in Japan will be discussed. Five facilities of hadron therapy are in operation and one facility will be in operation this year.
593135, 金井 達明, Kanai, Tatsuaki, 593134   +3 more
core  

A DNA damage multiscale model for NTCP in proton and hadron therapy. [PDF]

Med Phys, 2020
Abolfath R, Peeler C, Mirkovic D, Mohan R, Grosshans D.   +4 more
europepmc   +1 more source

CVD diamonds used in the ATLAS pixel detector and in hadron therapy

, 2016
A 13cm diameter wafer of polycrystalline CVD diamonds.
ATLAS Collaboration
core  

Detector design for range monitoring in hadron therapy by means of image reconstruction

, 2012
Hadron therapy offers some advantages over conventional therapy. However, small errors in particle range may significantly increase dose delivered to healthy tissue or produce incomplete coverage of the target volume. Consequently, developing a method to
R. Van Holen, F. Diblen, S. Espana, Van Holen, Roel, Vandenberghe, Stefaan, S. Vandenberghe, Diblen, Faruk, Espana Palomares, Samuel   +7 more
core   +1 more source

Linear_Accelerator_C+6_Ions_as_Injector_for_a_Synchrotron, Intended for Hadrons Therapy

, 2013
We consider acceleration light ions by the field of a traveling-wave in a helical waveguide. The frequency of the accelerating RF field f = 100 MHz, generator power P = 2 MW. Ion focusing is provided by a solenoidal magnetic field with the intensity B = 3.5 Tesla.
Dolya, S. N., Reshetnikova, K. A.
openaire   +2 more sources

High-power performance studies of an S-band high-gradient accelerating cavity for medical applications

Nuclear Engineering and Technology
High-Gradient accelerating cavities are one of the main research lines in the development of compact linear accelerators. However, the operation of such accelerating cavities is currently limited by non-linear electromagnetic effects that are intensified
P. Martinez-Reviriego, N. Fuster-Martínez, D. Esperante, M. Boronat, B. Gimeno, C. Blanch, D. González-Iglesias, P. Martín-Luna, E. Martínez, A. Menendez, L. Pedraza, J. Fernández, J. Fuster, A. Grudiev, N. Catalan Lasheras, W. Wuensch   +15 more
doaj   +1 more source